CureVac to Report Fourth Quarter and Full-Year 2021 Financial Results and Business Updates on April 28, 2022
April 22, 2022 at 07:15 AM EDT
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 22, 2022 / CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022. The company will host a conference call and webcast on the same day at 3 p.m. CET / 9 a.m. EST.
Conference call and webcast details
Dial-in numbers to participate in the conference call:
U.S. Toll-Free: +1-877-407-0989
The live webcast link can be accessed via the newsroom section of the CureVac website at https://www.curevac.com/en/newsroom/events/
Corresponding presentation slides will be posted shortly before the start of the webcast.
CureVac Investor Relations Contact
CureVac Media Contact
Forward-Looking Statements CureVac
For further information, please reference the company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC). You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.
View source version on accesswire.com: